Abstract
Annually, 2-3 millions non-melanoma and around 132,000 melanoma skin cancers occur globally and unfortunately these numbers are increasing, according to the World Health Organization. Surgical resection is only effective for initial lesions, and its recurrence can vary from 7 to 51%. Patient prognosis is highly dependent on early diagnosis, due its metastatic potential, and poor response to chemotherapy, radiotherapy, and immunotherapy. In Brazil, approximately 8,000 lesions are diagnosed per year, and melanoma is responsible for 80-85% of all deaths caused by skin cancer.
© 2014 Optical Society of America
PDF ArticleMore Like This
R. G. T. Rosa, S. Pratavieira, J. Jo, and C. Kurachi
FTu5C.2 Frontiers in Optics (FiO) 2017
Suresh Anand, Riccardo Cicchi, Alessandro Cosci, Susanna Rossari, Dimitrios Kapsokalyvas, Enrico Baria, Vincenza Maio, Daniela Massi, Vincenzo De Giorgi, Nicola Pimpinelli, and Francesco Saverio Pavone
95371R European Conference on Biomedical Optics (ECBO) 2015
Guillermo Marquez, Lihong V. Wang, Mehrube Mehrubeoglu, and Nasser Kehtarnavaz
SuG1 Biomedical Optical Spectroscopy and Diagnostics (BIOMED) 2000